shutterstock_2094533392_michael_vi
Michael Vi / Shutterstock.com
7 July 2022Big Pharma

USPTO and FDA unite to tackle drug pricing

The US Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) have partnered to facilitate access to affordable drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

More on this story

Americas
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

More on this story

Americas
9 June 2022   A bipartisan group of six US senators have asked the US Patent and Trademark Office to address ‘patent thickets’, a tactic that pharmaceutical companies allegedly use to stifle competition.
Americas
3 August 2020   The US government has agreed to pay up to $2.1 billion to Sanofi and GSK for the development and delivery of 100 million doses of a COVID-19 vaccine.
Big Pharma
6 September 2022   Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.